{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:41:49Z","timestamp":1787496109419,"version":"build-2736575974"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K23 CA 149076-01A1"],"award-info":[{"award-number":["K23 CA 149076-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016056"],"award-info":[{"award-number":["P30CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/ejcts\/ezx406","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T16:25:29Z","timestamp":1509553529000},"page":"656-663","source":"Crossref","is-referenced-by-count":20,"title":["Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer\u2020"],"prefix":"10.1093","volume":"53","author":[{"given":"Sai","family":"Yendamuri","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, NY, USA"},{"name":"Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Groman","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Demmy","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, NY, USA"},{"name":"Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hennon","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, NY, USA"},{"name":"Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Dexter","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, NY, USA"},{"name":"Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Picone","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, NY, USA"},{"name":"Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwumere","family":"Nwogu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, NY, USA"},{"name":"Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace K","family":"Dy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,13]]},"reference":[{"key":"key\n\t\t\t\t20180626050830_ezx406-B1","first-page":"351","article-title":"Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer","volume":"350","author":"Arriagada","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B2","first-page":"701","article-title":"Adjuvant chemotherapy for resected non-small-cell lung cancer\u2013ANITA takes the stage","volume":"7","author":"Azzoli","year":"2006","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B3","first-page":"157","article-title":"Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer","volume":"10","author":"Kato","year":"2005","journal-title":"Int J Clin Oncol"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B4","first-page":"1752","article-title":"Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial","volume":"21","author":"Betticher","year":"2003","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B5","first-page":"1","article-title":"Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer","volume":"21","author":"Roth","year":"1998","journal-title":"Lung Cancer"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B6","first-page":"102S","article-title":"The role of induction (neoadjuvant) chemotherapy in stage IIIA NSCLC","volume":"109","author":"Rosell","year":"1996","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B7","first-page":"199","article-title":"What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?","volume":"8","author":"Van Meerbeeck","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B8","first-page":"379","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial","volume":"374","author":"Albain","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B9","first-page":"142","article-title":"Complex thoracoscopic pulmonary resections for the treatment of lung cancer-a review","volume":"4","author":"Battoo","year":"2013","journal-title":"Indian J Surg Oncol"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B10","first-page":"1300","article-title":"Thoracoscopic pneumonectomy: an 11-year experience","volume":"146","author":"Battoo","year":"2014","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B11","first-page":"399","article-title":"VATS lobectomy has better perioperative outcomes than open lobectomy: CALGB 31001, an ancillary analysis of CALGB 140202 (Alliance)","volume":"99","author":"Nwogu","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B12","first-page":"296","article-title":"VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancer","volume":"8","author":"D'Amico","year":"2016","journal-title":"J Thorac Dis"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B13","first-page":"2269","article-title":"Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality","volume":"148","author":"Pezzi","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B14","first-page":"314","article-title":"Timing of surgery after neoadjuvant chemoradiation in locally advanced non-small cell lung cancer","volume":"12","author":"Gao","year":"2017","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B15","first-page":"55","article-title":"An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer","volume":"143","author":"Kim","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B16","first-page":"1247","article-title":"Management of stage IIIA (N2) non-small cell lung cancer: a transatlantic perspective","volume":"101","author":"Rocco","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B17","first-page":"1242","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B18","first-page":"930","article-title":"Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications","volume":"88","author":"Cerfolio","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B19","first-page":"1457","article-title":"Is pulmonary function damaged by neoadjuvant lung cancer therapy? A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery","volume":"139","author":"Margaritora","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B20","first-page":"843","article-title":"Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies","volume":"138","author":"Patel","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B21","first-page":"954","article-title":"Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis","volume":"15","author":"Toyooka","year":"2012","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B22","first-page":"1049","article-title":"Induction chemoradiation in stage IIIA\/N2 non-small-cell lung cancer:a phase 3 randomised trial","volume":"386","author":"Pless","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B23","first-page":"1807","article-title":"Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer","volume":"93","author":"Shah","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180626050830_ezx406-B24","first-page":"1380","article-title":"Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials","volume":"4","author":"Lim","year":"2009","journal-title":"J Thorac Oncol"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ejcts\/article-pdf\/53\/3\/656\/25085273\/ezx406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T05:15:45Z","timestamp":1529990145000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/53\/3\/656\/4740938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,13]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,12,13]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezx406","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,12,13]]}}}